Sarcoma
Results
Phase 1/2
This trial was done to find the best dose of selumetinib for people with Kaposi’s sarcoma who are also having treatment for HIV.
The trial was supported by Cancer Research UK. It was open for people to join between 2012 and 2016. The team published the results in 2025.
Recruitment start: 15 June 2012
Recruitment end: 31 December 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Robin Young
AstraZeneca
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Sheffield Teaching Hospitals NHS Foundation Trust
University of Birmingham
This is Cancer Research UK trial number CKUKD/11/005.
Last reviewed: 21 May 2025
CRUK internal database number: 8137
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
